These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

601 related articles for article (PubMed ID: 18061525)

  • 21. Prognostic value of activated Akt expression in oral squamous cell carcinoma.
    Lim J; Kim JH; Paeng JY; Kim MJ; Hong SD; Lee JI; Hong SP
    J Clin Pathol; 2005 Nov; 58(11):1199-205. PubMed ID: 16254112
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased ΔNp63 expression is predictive of malignant transformation in oral epithelial dysplasia and poor prognosis in oral squamous cell carcinoma.
    Matsubara R; Kawano S; Kiyosue T; Goto Y; Hirano M; Jinno T; Toyoshima T; Kitamura R; Oobu K; Nakamura S
    Int J Oncol; 2011 Dec; 39(6):1391-9. PubMed ID: 21833468
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of vascular endothelial growth factor-C does not predict occult lymph-node metastasis in early oral squamous cell carcinoma.
    Faustino SE; Oliveira DT; Nonogaki S; Landman G; Carvalho AL; Kowalski LP
    Int J Oral Maxillofac Surg; 2008 Apr; 37(4):372-8. PubMed ID: 18295452
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic significance of Bcl-2 and Bax protein expression in the patients with oral squamous cell carcinoma.
    Zhang M; Zhang P; Zhang C; Sun J; Wang L; Li J; Tian Z; Chen W
    J Oral Pathol Med; 2009 Mar; 38(3):307-13. PubMed ID: 18710422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. p73 expression for human buccal epithelial dysplasia and squamous cell carcinoma: does it correlate with nodal status of carcinoma and is there a relationship with malignant change of epithelial dysplasia?
    Chen YK; Hsue SS; Lin LM
    Head Neck; 2004 Nov; 26(11):945-52. PubMed ID: 15390192
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fragile histidine triad expression in oral squamous cell carcinoma and precursor lesions.
    Kujan O; Oliver R; Roz L; Sozzi G; Ribeiro N; Woodwards R; Thakker N; Sloan P
    Clin Cancer Res; 2006 Nov; 12(22):6723-9. PubMed ID: 17121892
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduced gamma-catenin expression and poor survival in oral squamous cell carcinoma.
    Närkiö-Mäkelä M; Pukkila M; Lagerstedt E; Virtaniemi J; Pirinen R; Johansson R; Kosunen A; Lappalainen K; Hämäläinen K; Kosma VM
    Arch Otolaryngol Head Neck Surg; 2009 Oct; 135(10):1035-40. PubMed ID: 19841345
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The expression of NMDA receptor 1 is associated with clinicopathological parameters and prognosis in the oral squamous cell carcinoma.
    Choi SW; Park SY; Hong SP; Pai H; Choi JY; Kim SG
    J Oral Pathol Med; 2004 Oct; 33(9):533-7. PubMed ID: 15357673
    [TBL] [Abstract][Full Text] [Related]  

  • 29. p21WAF1/CIP1 expression is a marker of poor prognosis in oral squamous cell carcinoma.
    Nemes JA; Nemes Z; Márton IJ
    J Oral Pathol Med; 2005 May; 34(5):274-9. PubMed ID: 15817070
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic and therapeutic relevance of NY-ESO-1 expression in oral squamous cell carcinoma.
    Ries J; Mollaoglu N; Vairaktaris E; Neukam FW; Nkenke E
    Anticancer Res; 2009 Dec; 29(12):5125-30. PubMed ID: 20044626
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The expression of E-cadherin at the invasive tumor front of oral squamous cell carcinoma: immunohistochemical and RT-PCR analysis with clinicopathological correlation.
    Wang X; Zhang J; Fan M; Zhou Q; Deng H; Aisharif MJ; Chen X
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Apr; 107(4):547-54. PubMed ID: 19327640
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protein and gene expression of tumor-associated antigen RCAS1 in esophageal squamous cell carcinoma.
    Ikeguchi M; Ohoro S; Maeda Y; Yamaguchi K; Fukuda K; Shirai H; Kondo A; Tsujitani S; Kaibara N
    Oncol Rep; 2003; 10(6):1891-4. PubMed ID: 14534714
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Expressions of receptor-binding cancer antigen expressed on SiSo cells, vascular endothelial growth factor, and matrix metalloproteinase-9 in cervical carcinoma and correlation thereof with the invasion and metastasis of the cancerous tissues].
    Liu R; Pu DM; Cheng YX; Yin L
    Zhonghua Yi Xue Za Zhi; 2007 May; 87(19):1326-9. PubMed ID: 17727777
    [TBL] [Abstract][Full Text] [Related]  

  • 34. p63 overexpression associates with poor prognosis in head and neck squamous cell carcinoma.
    Lo Muzio L; Santarelli A; Caltabiano R; Rubini C; Pieramici T; Trevisiol L; Carinci F; Leonardi R; De Lillo A; Lanzafame S; Bufo P; Piattelli A
    Hum Pathol; 2005 Feb; 36(2):187-94. PubMed ID: 15754296
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased placenta growth factor mRNA level is significantly associated with progression, recurrence and poor prognosis of oral squamous cell carcinoma.
    Cheng SJ; Cheng SL; Lee JJ; Chen HM; Chang HH; Kok SH; Chiang ML; Kuo MY
    J Formos Med Assoc; 2013 May; 112(5):253-8. PubMed ID: 23660220
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ki-67 from clinically and histologically "normal" distant mucosa as prognostic marker in early-stage (T1-T2N0) oral squamous cell carcinoma: a prospective study.
    Montebugnoli L; Gissi DB; Badiali G; Marchetti C; Cervellati F; Farnedi A; Foschini MP
    J Oral Maxillofac Surg; 2011 Oct; 69(10):2579-84. PubMed ID: 21292374
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overexpression of galectin-1 at the tumor invasion front is associated with poor prognosis in early-stage oral squamous cell carcinoma.
    Chiang WF; Liu SY; Fang LY; Lin CN; Wu MH; Chen YC; Chen YL; Jin YT
    Oral Oncol; 2008 Apr; 44(4):325-34. PubMed ID: 17588803
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The number of intratumoral dendritic cells and zeta-chain expression in T cells as prognostic and survival biomarkers in patients with oral carcinoma.
    Reichert TE; Scheuer C; Day R; Wagner W; Whiteside TL
    Cancer; 2001 Jun; 91(11):2136-47. PubMed ID: 11391595
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of survivin as a prognostic marker in oral squamous cell carcinoma.
    Kim YH; Kim SM; Kim YK; Hong SP; Kim MJ; Myoung H
    J Oral Pathol Med; 2010 May; 39(5):368-75. PubMed ID: 20050981
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of E-cadherin in cervical lymph nodes from primary oral squamous cell carcinoma patients.
    Zhong LP; Li J; Zhang CP; Zhu HG; Sun J; Zhang ZY
    Arch Oral Biol; 2007 Aug; 52(8):740-7. PubMed ID: 17331461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.